NO971564L - 1,2-difenylpyrrolderivater, deres fremstilling og deres terapeutiske bruk - Google Patents

1,2-difenylpyrrolderivater, deres fremstilling og deres terapeutiske bruk

Info

Publication number: NO971564L
Authority: NO; Norway
Prior art keywords: alkyl; hydrogen; optionally substituted; preparation; therapeutic use
Prior art date: 1996-04-05

Application number

NO971564A

Other languages

English (en)

Other versions

NO308736B1 (no

NO971564D0 (no

Inventor

Tomio Kimura

Yasuo Noguchi

Akira Nakao

Keisuke Suzuki

Shigeru Ushiyama

Akihiro Kawara

Masaaki Miyamoto

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-05

Filing date

1997-04-04

Publication date

1997-10-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13805966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO971564(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-04-04 Application filed by Sankyo Co filed Critical Sankyo Co

1997-04-04 Publication of NO971564D0 publication Critical patent/NO971564D0/no

1997-10-06 Publication of NO971564L publication Critical patent/NO971564L/no

2000-10-23 Publication of NO308736B1 publication Critical patent/NO308736B1/no

Links

ZZDIPNSMKJPHTR-UHFFFAOYSA-N 1,2-diphenylpyrrole Chemical class C=1C=CC=CC=1N1C=CC=C1C1=CC=CC=C1 ZZDIPNSMKJPHTR-UHFFFAOYSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
150000002431 hydrogen Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical group 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000000547 substituted alkyl group Chemical group 0.000 abstract 2
208000006386 Bone Resorption Diseases 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
230000003266 anti-allergic effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000001754 anti-pyretic effect Effects 0.000 abstract 1
239000002221 antipyretic Substances 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
230000024279 bone resorption Effects 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
150000002617 leukotrienes Chemical class 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Hematology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO971564A 1996-04-05 1997-04-04 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse NO308736B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP8356296		1996-04-05

Publications (3)

Publication Number	Publication Date
NO971564D0 NO971564D0 (no)	1997-04-04
NO971564L true NO971564L (no)	1997-10-06
NO308736B1 NO308736B1 (no)	2000-10-23

Family

ID=13805966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO971564A NO308736B1 (no)	1996-04-05	1997-04-04	1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse

Country Status (20)

Country	Link
US (2)	US5908858A (no)
EP (1)	EP0799823B1 (no)
JP (1)	JP3034819B2 (no)
KR (1)	KR100485426B1 (no)
CN (1)	CN1151126C (no)
AT (1)	ATE376998T1 (no)
CA (1)	CA2201812C (no)
CZ (1)	CZ293048B6 (no)
DE (1)	DE69738245T2 (no)
DK (1)	DK0799823T3 (no)
ES (1)	ES2296303T3 (no)
HU (1)	HU227830B1 (no)
ID (1)	ID17358A (no)
IL (1)	IL120584A (no)
NO (1)	NO308736B1 (no)
NZ (1)	NZ314508A (no)
PT (1)	PT799823E (no)
RU (1)	RU2125044C1 (no)
TW (1)	TW409122B (no)
ZA (1)	ZA972846B (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09212974A (ja) *	1996-01-31	1997-08-15	Mitsubishi Electric Corp	ディスク装置
KR100485642B1 (ko) *	1996-03-18	2005-09-30	에자이 가부시키가이샤	축합고리함유카르복실산유도체
SK285353B6 (sk)	1996-04-12	2006-11-03	G. D. Searle & Co.	Substituované benzénsulfónamidy ako proliečivá COX-2 inhibítorov, farmaceutická kompozícia a spôsobich prípravy a použitia
EP1369415A1 (en) *	1996-12-10	2003-12-10	G.D. Searle & Co.	Substituted pyrrolyl compounds for the treatment of inflammation
US5935990A (en) *	1996-12-10	1999-08-10	G.D. Searle & Co.	Substituted pyrrolyl compounds for the treatment of inflammation
US6887893B1 (en) *	1997-12-24	2005-05-03	Sankyo Company, Limited	Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
RU2220721C2 (ru) *	1997-12-24	2004-01-10	Санкио Компани, Лимитед	Активный агент для ингибирования роста опухолей у млекопитающих, лечения и/или профилактики связанных с опухолями нарушений и метастаз опухолей у млекопитающих
AU3953899A (en) *	1998-05-27	1999-12-13	Nippon Shinyaku Co. Ltd.	Cyclooxygenase-2 inhibitors
WO2000001688A1 (en) *	1998-07-02	2000-01-13	Sankyo Company, Limited	Five-membered heteroaryl compounds
RU2190399C2 (ru) *	1998-07-21	2002-10-10	Санкио Компани Лимитед	Средство для лечения и предотвращения кахексии
US6649645B1 (en)	1998-12-23	2003-11-18	Pharmacia Corporation	Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
US7122666B2 (en)	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
AU7961100A (en) *	1999-10-28	2001-05-08	Daiichi Pharmaceutical Co., Ltd.	Drug discharge pump inhibitors
ATE283048T1 (de)	1999-12-08	2004-12-15	Pharmacia Corp	Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
US6376489B1 (en) *	1999-12-23	2002-04-23	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
CA2393724A1 (en) *	1999-12-23	2001-06-28	Nitromed, Inc.	Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US6372777B1 (en) *	1999-12-23	2002-04-16	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
RU2198170C2 (ru) *	1999-12-27	2003-02-10	Санкио Компани, Лимитед	Производные пиррола, фармацевтические композиции на их основе и способ лечения
US6440994B1 (en) *	2000-03-29	2002-08-27	Richard J. Sanders, Jr.	Method of treating acne
MY137736A (en)	2001-04-03	2009-03-31	Pharmacia Corp	Reconstitutable parenteral composition
WO2002080974A1 (en) *	2001-04-04	2002-10-17	Sankyo Company, Limited	Novel medicinal use of cytokine production inhibitor
US20030105144A1 (en)	2001-04-17	2003-06-05	Ping Gao	Stabilized oral pharmaceutical composition
US6673818B2 (en)	2001-04-20	2004-01-06	Pharmacia Corporation	Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
AR038957A1 (es)	2001-08-15	2005-02-02	Pharmacia Corp	Terapia de combinacion para el tratamiento del cancer
GB0212785D0 (en) *	2002-05-31	2002-07-10	Glaxo Group Ltd	Compounds
AU2003279622A1 (en) *	2002-06-28	2004-01-19	Nitromed, Inc.	Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
JP4458514B2 (ja) *	2002-07-18	2010-04-28	第一三共株式会社	高純度のエナミン類の製造方法
CA2496225C (en)	2002-08-20	2012-08-07	Sankyo Company Limited	Process for the production of .gamma.-keto acetals
JP4601274B2 (ja) *	2002-08-20	2010-12-22	第一三共株式会社	γ−ケトアセタール類の製造方法
GB0225548D0 (en)	2002-11-01	2002-12-11	Glaxo Group Ltd	Compounds
RU2308264C2 (ru) *	2002-12-02	2007-10-20	Каунсел Оф Сайнтифик Энд Индастриал Рисерч	Способ профилактики и/или лечения астмы с использованием рврв
WO2004054560A1 (en)	2002-12-13	2004-07-01	Warner-Lambert Company Llc	Alpha-2-delta ligand to treat lower urinary tract symptoms
ES2394782T3 (es) *	2003-05-07	2013-02-05	Osteologix A/S	Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos
EP1745791B1 (en) *	2003-05-07	2013-06-26	Osteologix A/S	Treating cartilage/bone conditions with water-soluble strontium salts
GB0328024D0 (en) *	2003-12-03	2004-01-07	Glaxo Group Ltd	Compounds
BRPI0506994A (pt)	2004-01-22	2007-07-03	Pfizer	derivados de triazol que inibem a atividade antagonista da vasopressina
KR20080064956A (ko) *	2005-09-27	2008-07-10	미리어드 제네틱스, 인크.	치료학적 화합물로서의 피롤 유도체
US20070167510A1 (en) *	2006-01-13	2007-07-19	Suzanne Lentzsch	Methods for inhibiting osteoclastogenesis
AU2007265116A1 (en) *	2006-06-27	2008-01-03	Abbott Laboratories	Pyrrole derivatives and their methods of use
EP1889617A1 (en) *	2006-07-11	2008-02-20	Freie Universität Berlin	Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents
EP2059504B1 (en)	2006-08-03	2015-09-09	Rottapharm Biotech S.r.l.	3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors
TW200812950A (en) *	2006-08-18	2008-03-16	Daiichi Sankyo Co Ltd	Process for producing acetophenone bromide
CA2662870A1 (en) *	2006-09-07	2008-03-13	Myriad Genetics, Inc.	Therapeutic compounds for diseases and disorders
CA2673545A1 (en)	2006-12-22	2008-07-03	Recordati Ireland Limited	Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
CA2676413A1 (en) *	2007-01-19	2008-07-31	Mallinckrodt Inc.	Diagnostic and therapeutic cyclooxygenase-2 binding ligands
CA2692973A1 (en) *	2007-07-12	2009-01-15	Tragara Pharmaceuticals, Inc.	Patient selection and therapeutic methods using markers of prostaglandin metabolism
EP2170062A4 (en) *	2007-07-12	2010-12-29	Tragara Pharmaceuticals Inc	METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER DISORDERS, TUMORS AND TUMOR-DISORDED DISEASES
CA2700673A1 (en) *	2007-09-24	2009-04-02	Tragara Pharmaceuticals, Inc.	Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors
EP2284154A1 (en) *	2009-07-29	2011-02-16	Argon Pharma S.L.	Antitumor 1,2-diphenylpyrrole compounds and their preparation process
ES2372769B1 (es) *	2010-07-08	2012-12-03	Universitat De Barcelona	Fenil metil sulfonas con actividad antiiflamatoria y actividad antitumoral.
WO2012131576A1 (en) *	2011-03-31	2012-10-04	Lupin Limited	Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
JP2020527539A (ja)	2017-07-18	2020-09-10	フイルメニツヒソシエテアノニムＦｉｒｍｅｎｉｃｈＳａ	シクラメンにおい物質
WO2022195579A1 (en)	2021-03-15	2022-09-22	Saul Yedgar	Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1356901A (fr)	1958-03-13	1964-04-03		Nouveaux aminoétheroxydes, aminothioéthers et aminoesters dérivés du pyrrole, etleur procédé de préparation
US3168532A (en)	1963-06-12	1965-02-02	Parke Davis & Co	1, 5-diarylpyrrole-2-propionic acid compounds
US3168531A (en)	1963-06-12	1965-02-02	Parke Davis & Co	1-aryl-5-(p-lower alkoxyphenyl)-pyrrole-2-propionic acid compounds
US3285931A (en)	1964-12-21	1966-11-15	Union Carbide Corp	Preparation of substituted pyrrole derivatives
US3427305A (en) *	1966-11-01	1969-02-11	Searle & Co	5 - ((halo/alkoxy)phenyl) - 1 - (p - sulfonamido(phenyl/benzyl)) - 2 - pyrrolepropionic acids
US3551571A (en)	1967-05-19	1970-12-29	Endo Lab	Methods for reducing pain,reducing fever and alleviating inflammatory syndromes with heteroaromatic pyrrol-3-yl ketones
GB1271082A (en)	1968-05-07	1972-04-19	Wyeth John & Brother Ltd	Furan, pyrrole and thiophene derivatives
FR2054474A2 (en)	1969-07-09	1971-04-23	Innothera Lab Sa	Analgesic, antiinflammatory 1-phenyl-2, 5-di
DE1938904A1 (de) *	1968-08-02	1970-02-05	Innothera Lab Sa	1-Phenylpyrrole
US3714232A (en)	1969-06-25	1973-01-30	Merck & Co Inc	5-arylphenyl sulfonic acids
DE2419970C3 (de)	1974-04-25	1980-06-12	Hoechst Ag, 6000 Frankfurt	3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung
US4093735A (en)	1974-04-25	1978-06-06	Hoechst Aktiengesellschaft	5-Sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent
CH628622A5 (de)	1976-12-24	1982-03-15	Ciba Geigy Ag	Verfahren zur herstellung von neuen in 4-stellung substituierten 3-sulfamoylbenzoesaeuren.
US4335136A (en)	1980-04-18	1982-06-15	E. I. Du Pont De Nemours And Company	Anti-inflammatory 4,5-diaryl-α-(polyfluoroalkyl)-1H-pyrrole-2-methanamines
DE3309355A1 (de)	1983-03-16	1984-09-27	Basf Ag, 6700 Ludwigshafen	Verfahren zur herstellung von pyrrolen
US4694018A (en) *	1985-11-29	1987-09-15	G. D. Serale & Co.	Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
US4792568A (en)	1986-04-14	1988-12-20	Rorer Pharmaceutical Corporation	Aryl pyrroles as useful antiallergy compounds
NO881411L (no)	1987-04-14	1988-10-17	Bayer Ag	Substituerte pyrroler.
US5010098A (en) *	1987-07-29	1991-04-23	American Cyanamid Company	Arylpyrrole insecticidal acaricidal and nematicidal agents and methods for the preparation thereof
US5455263A (en) *	1987-07-29	1995-10-03	American Cyanamid Company	Methods for the control and the protection of warm-blooded animals against infestation and infection by helminths, acarids and arthropod endo- and ectoparasites
DE3727114A1 (de)	1987-08-14	1989-02-23	Basf Ag	Verfahren zur herstellung von pyrrolen
CA1334975C (en)	1987-11-13	1995-03-28	James H. Holms	Furan and pyrrole containing lipoxygenase inhibiting compounds
AU641905B2 (en) *	1988-12-09	1993-10-07	Rhone-Poulenc Agrochimie	1-substituted-phenyl pyrrole derivatives as insecticides and methods for their production
US5096919A (en)	1989-01-05	1992-03-17	Ciba-Geigy Corporation	Pyrrolylphenyl-substituted hydroxamic acid derivatives
DE3903993A1 (de) *	1989-02-10	1990-08-16	Basf Ag	Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus
WO1991000093A1 (en)	1989-06-26	1991-01-10	The Research Foundation Of State University Of New York	Bis-acyloxymethyl derivatives
PH27357A (en) *	1989-09-22	1993-06-21	Fujisawa Pharmaceutical Co	Pyrazole derivatives and pharmaceutical compositions comprising the same
DD298912A5 (de)	1989-11-17	1992-03-19	��@��@��k��	Verfahren zur herstellung von 3-aminopyrrolen
IL98784A0 (en) *	1990-07-17	1992-07-15	Lilly Co Eli	Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5157047A (en) *	1990-10-18	1992-10-20	American Cyanamid Company	Bis- and tris(trifluoromethyl)arylpyrrole insecticidal and acaricidal agents
DE4036706A1 (de)	1990-11-17	1992-05-21	Hoechst Ag	Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
US5128485A (en)	1990-12-17	1992-07-07	American Cyanamid Company	Synthesis of 2-aryl-5-(trifluoromethyl)pyrroles useful as pesticidal agents and as intermediates for the preparation of said agents
US5118816A (en) *	1990-12-26	1992-06-02	American Cyanamid Company	2-aryl-5-(trifluoromethyl)-2-pyrroline compounds useful in the manufacture of insecticidal, nematocidal and acaricidal arylpyrroles
US5144041A (en)	1990-12-26	1992-09-01	American Cyanamid Company	Process for the preparation of 2-aryl-1-substituted-5-(trifluoromethyl) pyrrole compounds useful as insecticidal, acaricidal and nematocidal agents and as intermediates for the manufacture of said agents
JPH051027A (ja)	1991-04-09	1993-01-08	Nippon Bayeragrochem Kk	新規２−又は３−クロロピロール類及びその製造方法
US5254713A (en)	1991-04-09	1993-10-19	Nihon Bayer Agrochem K.K.	2- and 3-chloropyrroles and process for preparing the same
YU8592A (sh)	1991-08-28	1994-06-10	Flumroc Ag.	Postupak i uređaj za izradu ploča od mineralnih vlakana primenjenih kao nosač zidnog premaza
US5928635A (en)	1994-12-07	1999-07-27	Schmidt; Karlheinz	Process for producing active agent complexes
EP0764644A1 (en) *	1993-01-15	1997-03-26	G.D. Searle & Co.	Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a gastrointestinal condition
US5380738A (en) *	1993-05-21	1995-01-10	Monsanto Company	2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US5474995A (en)	1993-06-24	1995-12-12	Merck Frosst Canada, Inc.	Phenyl heterocycles as cox-2 inhibitors
US5344991A (en) *	1993-10-29	1994-09-06	G.D. Searle & Co.	1,2 diarylcyclopentenyl compounds for the treatment of inflammation
US5434178A (en) *	1993-11-30	1995-07-18	G.D. Searle & Co.	1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
ES2141916T3 (es) *	1993-11-30	2000-04-01	Searle & Co	Pirazolil-bencenosulfonamidas sustituidas para el tratamiento de la inflamacion.
US5418254A (en) *	1994-05-04	1995-05-23	G. D. Searle & Co.	Substituted cyclopentadienyl compounds for the treatment of inflammation
US5496845A (en)	1994-05-25	1996-03-05	American Cyanamid Co.	Suspension concentrate compositions of arylpyrrole insecticidal and acaricidal agents
US5486534A (en) *	1994-07-21	1996-01-23	G. D. Searle & Co.	3,4-substituted pyrazoles for the treatment of inflammation
EP0772606A1 (en) *	1994-07-27	1997-05-14	G.D. SEARLE & CO.	Substituted thiazoles for the treatment of inflammation
US5620999A (en) *	1994-07-28	1997-04-15	Weier; Richard M.	Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5616601A (en) *	1994-07-28	1997-04-01	Gd Searle & Co	1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US5521213A (en)	1994-08-29	1996-05-28	Merck Frosst Canada, Inc.	Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
GB2294879A (en)	1994-10-19	1996-05-15	Merck & Co Inc	Cylcooxygenase-2 Inhibitors
JP2636819B2 (ja) *	1994-12-20	1997-07-30	日本たばこ産業株式会社	オキサゾール系複素環式芳香族化合物
ES2183935T3 (es) *	1995-02-13	2003-04-01	Searle & Co	Isoxazoles sustituidos para el tratamiento de la inflamacion.
US5643933A (en)	1995-06-02	1997-07-01	G. D. Searle & Co.	Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5700816A (en)	1995-06-12	1997-12-23	Isakson; Peter C.	Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
DE69635048T2 (de)	1995-06-12	2006-02-16	G.D. Searle & Co.	Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
US5792778A (en)	1995-08-10	1998-08-11	Merck & Co., Inc.	2-substituted aryl pyrroles, compositions containing such compounds and methods of use
KR19990064310A (ko)	1995-10-17	1999-07-26	윌리암스 로저 에이	시클로옥시게나제-2의 검출방법
US6022886A (en)	1996-02-01	2000-02-08	Smithkline Beecham Corporation	Endothelin receptor antagonists
SK285353B6 (sk) *	1996-04-12	2006-11-03	G. D. Searle & Co.	Substituované benzénsulfónamidy ako proliečivá COX-2 inhibítorov, farmaceutická kompozícia a spôsobich prípravy a použitia
US5935990A (en)	1996-12-10	1999-08-10	G.D. Searle & Co.	Substituted pyrrolyl compounds for the treatment of inflammation
US5972986A (en)	1997-10-14	1999-10-26	G.D. Searle & Co.	Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
US6025353A (en)	1997-11-19	2000-02-15	G.D. Searle & Co.	Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
DE19812059C1 (de) *	1998-03-19	1999-09-23	Wella Ag	Diaminobenzol-Derivate sowie diese Diaminobenzol-Derivate enthaltende Haarfärbemittel
US8887786B2 (en) *	2011-03-07	2014-11-18	Hunter Douglas Inc.	Control for movable rail

1997
- 1997-03-26 US US08/824,775 patent/US5908858A/en not_active Ceased
- 1997-04-01 IL IL12058497A patent/IL120584A/xx not_active IP Right Cessation
- 1997-04-02 AT AT97302245T patent/ATE376998T1/de active
- 1997-04-02 NZ NZ314508A patent/NZ314508A/xx not_active IP Right Cessation
- 1997-04-02 DE DE69738245T patent/DE69738245T2/de not_active Expired - Lifetime
- 1997-04-02 DK DK97302245T patent/DK0799823T3/da active
- 1997-04-02 EP EP97302245A patent/EP0799823B1/en not_active Expired - Lifetime
- 1997-04-02 ES ES97302245T patent/ES2296303T3/es not_active Expired - Lifetime
- 1997-04-02 PT PT97302245T patent/PT799823E/pt unknown
- 1997-04-03 KR KR1019970012430A patent/KR100485426B1/ko not_active Expired - Fee Related
- 1997-04-03 ZA ZA9702846A patent/ZA972846B/xx unknown
- 1997-04-03 TW TW086104297A patent/TW409122B/zh not_active IP Right Cessation
- 1997-04-04 CA CA002201812A patent/CA2201812C/en not_active Expired - Fee Related
- 1997-04-04 NO NO971564A patent/NO308736B1/no not_active IP Right Cessation
- 1997-04-04 HU HU9700709A patent/HU227830B1/hu not_active IP Right Cessation
- 1997-04-04 ID IDP971140A patent/ID17358A/id unknown
- 1997-04-04 CZ CZ19971035A patent/CZ293048B6/cs not_active IP Right Cessation
- 1997-04-04 JP JP9086889A patent/JP3034819B2/ja not_active Expired - Fee Related
- 1997-04-04 RU RU97105191A patent/RU2125044C1/ru not_active IP Right Cessation
- 1997-04-05 CN CNB971134049A patent/CN1151126C/zh not_active Expired - Fee Related
2000
- 2000-09-29 US US09/678,218 patent/USRE39420E1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
TW409122B (en)	2000-10-21
DE69738245T2 (de)	2008-08-14
PT799823E (pt)	2008-01-15
KR100485426B1 (ko)	2005-10-12
ID17358A (id)	1997-12-24
CZ103597A3 (en)	1997-10-15
AU710380B2 (en)	1999-09-16
JPH09323971A (ja)	1997-12-16
CZ293048B6 (cs)	2004-01-14
ZA972846B (en)	1997-11-04
EP0799823A1 (en)	1997-10-08
NO308736B1 (no)	2000-10-23
KR970069985A (ko)	1997-11-07
HK1003268A1 (en)	1998-10-23
NZ314508A (en)	1999-06-29
DK0799823T3 (da)	2008-03-03
JP3034819B2 (ja)	2000-04-17
DE69738245D1 (de)	2007-12-13
ES2296303T3 (es)	2008-04-16
USRE39420E1 (en)	2006-12-05
US5908858A (en)	1999-06-01
NO971564D0 (no)	1997-04-04
AU1665397A (en)	1997-10-09
IL120584A0 (en)	1997-08-14
CA2201812A1 (en)	1997-10-05
CN1151126C (zh)	2004-05-26
ATE376998T1 (de)	2007-11-15
HUP9700709A2 (hu)	1999-05-28
CA2201812C (en)	2007-09-18
EP0799823B1 (en)	2007-10-31
RU2125044C1 (ru)	1999-01-20
HU9700709D0 (en)	1997-05-28
IL120584A (en)	2003-10-31
HUP9700709A3 (en)	2000-04-28
HU227830B1 (hu)	2012-05-02
CN1168372A (zh)	1997-12-24

Legal Events

Date	Code	Title	Description
2015-11-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO971564L (no)	1997-10-06	1,2-difenylpyrrolderivater, deres fremstilling og deres terapeutiske bruk
DK0850926T3 (da)	2003-02-17	Difluorprostaglandinderivater og deres anvendelse
NO922147L (no)	1992-12-01	Heterocykliske derivater
ATE260255T1 (de)	2004-03-15	5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
NO941052L (no)	1994-09-26	Benzimidazolforbindelser, deres anvendelse og fremstilling
FR2800735B1 (fr)	2002-02-01	Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
DE69326395D1 (de)	1999-10-21	Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
NO161564C (no)	1989-08-30	Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
ATE79257T1 (de)	1992-08-15	Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE60002558D1 (de)	2003-06-12	Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
DE69828197D1 (de)	2005-01-20	Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
NO173991C (no)	1994-03-02	Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
ES2193047T3 (es)	2003-11-01	(3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas.
ATE212842T1 (de)	2002-02-15	Quinoxalin-derivate zur behandlung von tinnitus
ATE283269T1 (de)	2004-12-15	5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
ATE151987T1 (de)	1997-05-15	Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
DE69902142D1 (de)	2002-08-22	Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE3782229D1 (de)	1992-11-19	Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DK0638587T3 (da)	1999-11-22	Salmyciner, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel